Today, Razib talks to Zack Raborn, VP of operations at CRISPR QC, a new company aimed at improving quality control in the development of CRISPR technology. Razib and Raborn talk about the basics of CRISPR-Cas9, and how it is now being applied, and how it could be applied in the future. Raborn also highlights how far we need to go in terms of the CRISPR technology to make it widespread and applicable in the context of healthcare, and how CRISPR QC fits into this new ecosystem.